SPY—QQQ—BTC/USD—DIA—GLD—TLT—
Benzinga
Updated: Oct 18, 2026

Michael Yee's Stock Ratings

UBS Analyst

Michael Yee is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Overall Average Return

14.0%

Smart Score

67.8%

Overall Average Return Percentile

69th

Number of Ratings

100
Buy NowGet Alert
10/09/2026BIIBBuy Now
Biogen
$236.0014.41%$240 → $270MaintainsBuyGet Alert
10/09/2026AMGNBuy Now
Amgen
$424.9410.6%$430 → $470MaintainsBuyGet Alert
10/09/2026ABBVBuy Now
AbbVie
$282.60-2.69%$260 → $275MaintainsNeutralGet Alert
09/28/2026VRTXBuy Now
Vertex Pharmaceuticals
$512.1420.08%$585 → $615MaintainsBuyGet Alert
09/28/2026KODBuy Now
Kodiak Sciences
$91.3231.41%$80 → $120MaintainsBuyGet Alert
09/11/2026KRSABuy Now
Korsana Biosciences
$31.8672.63% → $55Initiates → BuyGet Alert
09/02/2026JNJBuy Now
Johnson & Johnson
$253.7926.09%$280 → $320MaintainsBuyGet Alert
08/28/2026RVMDBuy Now
Revolution Medicines
$181.3646.12%$220 → $265MaintainsBuyGet Alert
08/20/2026MRNABuy Now
Moderna
$227.50-34.07%$50 → $150MaintainsNeutralGet Alert
08/20/2026MRKBuy Now
Merck & Co
$143.8521.65%$145 → $175MaintainsBuyGet Alert
08/10/2026TRAXBuy Now
First Tracks
$36.2879.16%$45 → $65MaintainsBuyGet Alert
08/07/2026DNLIBuy Now
Denali Therapeutics
$17.9589.42%$25 → $34MaintainsBuyGet Alert
08/05/2026AMGNBuy Now
Amgen
$424.943.54%$420 → $440MaintainsBuyGet Alert
07/30/2026BIIBBuy Now
Biogen
$236.001.69%$225 → $240MaintainsBuyGet Alert
07/13/2026LLYBuy Now
Eli Lilly
$1.24K14.72%$1250 → $1425MaintainsBuyGet Alert
07/13/2026ABBVBuy Now
AbbVie
$282.60-8%$230 → $260MaintainsNeutralGet Alert
07/13/2026AMGNBuy Now
Amgen
$424.94-1.16%$400 → $420MaintainsBuyGet Alert
07/13/2026VRTXBuy Now
Vertex Pharmaceuticals
$512.1414.23%$545 → $585MaintainsBuyGet Alert
07/01/2026ORKABuy Now
Oruka Therapeutics
$74.0075.68%$100 → $130MaintainsBuyGet Alert
06/23/2026APGEBuy Now
Apogee Therapeutics
——$100 → $135.11DowngradeBuy → NeutralGet Alert
06/15/2026JBIOBuy Now
Jade Biosciences
$13.83225.38% → $45Initiates → BuyGet Alert
05/13/2026ANABBuy Now
AnaptysBio
$50.8849.37%$60 → $76MaintainsBuyGet Alert
04/28/2026ORKABuy Now
Oruka Therapeutics
$74.0035.14%$75 → $100MaintainsBuyGet Alert
04/22/2026BIIBBuy Now
Biogen
$236.00-4.66%$185 → $225UpgradeNeutral → BuyGet Alert
04/21/2026TRAXBuy Now
First Tracks
$36.2824.04% → $45Initiates → BuyGet Alert
04/21/2026ANABBuy Now
AnaptysBio
$50.8817.92%$90 → $60MaintainsBuyGet Alert
04/13/2026AMGNBuy Now
Amgen
$424.94-5.87%$390 → $400MaintainsBuyGet Alert
04/13/2026MRKBuy Now
Merck & Co
$143.850.8%$130 → $145MaintainsBuyGet Alert
04/13/2026PFEBuy Now
Pfizer
$29.43-8.26%$25 → $27MaintainsNeutralGet Alert
04/06/2026ORKABuy Now
Oruka Therapeutics
$74.001.35%$50 → $75MaintainsBuyGet Alert
03/27/2026KODBuy Now
Kodiak Sciences
$91.32-12.4%$50 → $80MaintainsBuyGet Alert
03/17/2026SDGRBuy Now
Schrodinger
$22.98-43.43%$18 → $13MaintainsNeutralGet Alert
03/17/2026ANABBuy Now
AnaptysBio
$50.8876.89%$70 → $90MaintainsBuyGet Alert
03/03/2026NUVBBuy Now
Nuvation Bio
$4.4258.37%$10 → $7MaintainsNeutralGet Alert
02/24/2026ACLXBuy Now
Arcellx
——$100 → $115DowngradeBuy → NeutralGet Alert
02/17/2026GLTOBuy Now
Galecto
—— → $45Initiates → BuyGet Alert
02/05/2026ABBVBuy Now
AbbVie
$282.60-18.61%$240 → $230MaintainsNeutralGet Alert
01/26/2026VRTXBuy Now
Vertex Pharmaceuticals
$512.146.42%$535 → $545MaintainsBuyGet Alert
01/26/2026GILDBuy Now
Gilead Sciences
$153.331.09%$145 → $155MaintainsBuyGet Alert
01/26/2026AMGNBuy Now
Amgen
$424.94-8.22%$380 → $390MaintainsBuyGet Alert
01/08/2026VTYXBuy Now
Ventyx Biosciences
——$20 → $14DowngradeBuy → NeutralGet Alert
01/07/2026ACLXBuy Now
Arcellx
—— → $100AssumesBuy → BuyGet Alert
01/07/2026IDYABuy Now
IDEAYA Biosciences
$33.8147.89% → $50AssumesBuy → BuyGet Alert
01/07/2026DNLIBuy Now
Denali Therapeutics
$17.9539.28% → $25AssumesBuy → BuyGet Alert
01/07/2026IMCRBuy Now
Immunocore Holdings
$29.8484.32%$24 → $55AssumesSell → BuyGet Alert
01/07/2026IVABuy Now
Inventiva
$3.05293.44%$3 → $12AssumesNeutral → BuyGet Alert
01/07/2026ANABBuy Now
AnaptysBio
$50.8837.58%$20 → $70AssumesNeutral → BuyGet Alert
01/07/2026VRDNBuy Now
Viridian Therapeutics
$20.65142.13% → $50Initiates → BuyGet Alert
01/07/2026SRRKBuy Now
Scholar Rock Holding
$40.2449.11% → $60Initiates → BuyGet Alert
01/07/2026VTYXBuy Now
Ventyx Biosciences
—— → $20Initiates → BuyGet Alert
01/07/2026SDGRBuy Now
Schrodinger
$22.98-21.68% → $18Initiates → NeutralGet Alert
01/07/2026SABSBuy Now
SAB Biotherapeutics
$2.58171.32% → $7Initiates → BuyGet Alert
01/07/2026ORKABuy Now
Oruka Therapeutics
$74.00-32.43% → $50Initiates → BuyGet Alert
01/07/2026OLMABuy Now
Olema Pharmaceuticals
$7.11532.91% → $45Initiates → BuyGet Alert
01/07/2026NUVBBuy Now
Nuvation Bio
$4.42126.24% → $10Initiates → NeutralGet Alert
01/07/2026MBXBuy Now
MBX Biosciences
$52.4814.33% → $60Initiates → BuyGet Alert
01/07/2026KODBuy Now
Kodiak Sciences
$91.32-45.25% → $50Initiates → BuyGet Alert
01/07/2026BEAMBuy Now
Beam Therapeutics
$24.0316.52% → $28Initiates → NeutralGet Alert
01/07/2026ALLOBuy Now
Allogene Therapeutics
$1.31511.62% → $8Initiates → BuyGet Alert
01/07/2026ZLABBuy Now
Zai Lab
$24.0645.47% → $35Initiates → BuyGet Alert
01/07/2026ALGSBuy Now
Aligos Therapeutics
$5.53261.66% → $20Initiates → BuyGet Alert
01/07/2026BMYBuy Now
Bristol-Myers Squibb
$58.8110.52%$46 → $65UpgradeNeutral → BuyGet Alert
01/07/2026ABBVBuy Now
AbbVie
$282.60-15.07%$220 → $240AssumesNeutral → NeutralGet Alert
01/07/2026GILDBuy Now
Gilead Sciences
$153.33-5.43%$112 → $145AssumesNeutral → BuyGet Alert
01/07/2026BIIBBuy Now
Biogen
$236.00-21.61%$130 → $185AssumesNeutral → NeutralGet Alert
01/07/2026PFEBuy Now
Pfizer
$29.43-15.05% → $25AssumesNeutral → NeutralGet Alert
01/07/2026VRTXBuy Now
Vertex Pharmaceuticals
$512.144.46%$546 → $535AssumesBuy → BuyGet Alert
01/07/2026LLYBuy Now
Eli Lilly
$1.24K0.64%$1080 → $1250AssumesBuy → BuyGet Alert
01/07/2026AMGNBuy Now
Amgen
$424.94-10.58%$317 → $380AssumesNeutral → BuyGet Alert
07/08/2025CRGXBuy Now
Cargo Therapeutics
——$3.7 → $5MaintainsHoldGet Alert
03/17/2025BPMCBuy Now
Blueprint Medicines
—— → $135Initiates → BuyGet Alert
03/06/2025ALXOBuy Now
ALX Oncology Holdings
$1.04188.46%$2 → $3UpgradeHold → BuyGet Alert
01/30/2025CRGXBuy Now
Cargo Therapeutics
——$32 → $3DowngradeBuy → HoldGet Alert
12/19/2024ALXOBuy Now
ALX Oncology Holdings
$1.0492.31%$12 → $2DowngradeBuy → HoldGet Alert
12/09/2024KODBuy Now
Kodiak Sciences
$91.32-78.1% → $20UpgradeHold → BuyGet Alert
12/09/2024BIIBBuy Now
Biogen
$236.00-23.73%$250 → $180DowngradeBuy → HoldGet Alert
12/09/2024VRTXBuy Now
Vertex Pharmaceuticals
$512.147.39%$500 → $550UpgradeHold → BuyGet Alert
11/12/2024AMGNBuy Now
Amgen
$424.94-10.58%$380 → $380MaintainsBuyGet Alert
11/01/2024DNLIBuy Now
Denali Therapeutics
$17.95150.7%$40 → $45MaintainsBuyGet Alert
10/15/2024MRNABuy Now
Moderna
$227.50-75.82%$65 → $55MaintainsHoldGet Alert
10/08/2024MBXBuy Now
MBX Biosciences
$52.48-33.31% → $35Initiates → BuyGet Alert
09/13/2024MRNABuy Now
Moderna
$227.50-71.43%$120 → $65DowngradeBuy → HoldGet Alert
09/13/2024ORKABuy Now
Oruka Therapeutics
$74.00-45.95% → $40Initiates → BuyGet Alert
07/17/2024AXONBuy Now
Axon Enterprise
$386.00-0.26% → $385Initiates → BuyGet Alert
04/09/2024MRNABuy Now
Moderna
$227.50-45.05% → $125ReiteratesBuy → BuyGet Alert
03/27/2024NUVBBuy Now
Nuvation Bio
$4.42126.24%$1.4 → $10UpgradeHold → BuyGet Alert
03/22/2024CRGXBuy Now
Cargo Therapeutics
——$28 → $32MaintainsBuyGet Alert
03/15/2024IMRXBuy Now
Immuneering
$3.58-16.25%$16 → $3DowngradeBuy → HoldGet Alert
12/22/2023LIANBuy Now
LianBio
——$7 → $4DowngradeBuy → HoldGet Alert
12/22/2023CEREBuy Now
Cerevel Therapeutics Hldg
——$40 → $45DowngradeBuy → HoldGet Alert
12/08/2023BEAMBuy Now
Beam Therapeutics
$24.0324.84%$75 → $30DowngradeBuy → HoldGet Alert
12/08/2023ALXOBuy Now
ALX Oncology Holdings
$1.041630.77%$8 → $18UpgradeHold → BuyGet Alert
12/05/2023CRGXBuy Now
Cargo Therapeutics
—— → $28Initiates → BuyGet Alert
10/25/2023AMRNBuy Now
Amarin Corp
$11.98-91.65%$3 → $1DowngradeBuy → HoldGet Alert
10/25/2023SRRKBuy Now
Scholar Rock Holding
$40.24-50.3% → $20UpgradeHold → BuyGet Alert
10/12/2023AMGNBuy Now
Amgen
$424.94-27.05%$310 → $310ReiteratesBuy → BuyGet Alert
10/10/2023RYZBBuy Now
RayzeBio
—— → $35Initiates → BuyGet Alert
08/14/2023AMGNBuy Now
Amgen
$424.94-27.05%$275 → $310MaintainsBuyGet Alert
07/24/2023KODBuy Now
Kodiak Sciences
$91.32-96.71% → $3DowngradeBuy → HoldGet Alert
05/10/2023RXDXBuy Now
Prometheus Biosciences
——$160 → $200DowngradeBuy → HoldGet Alert

Recent Analyst Stock Rating News

Transcript: Johnson & Johnson Q3 2026 Earnings Conference Call
Transcript: Johnson & Johnson Q3 2026 Earnings Conference Call
Johnson & Johnson (NYSE:JNJ) held its third-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to
Denali Therapeutics Q2 2026 Earnings Call Transcript
Denali Therapeutics Q2 2026 Earnings Call Transcript
On Thursday, Denali Therapeutics (NASDAQ:DNLI) discussed second-quarter financial results during its earnings call. The full transcript is provided below. Benzinga APIs provide real-time access to earnings call
Transcript: Eli Lilly Q2 2026 Earnings Conference Call
Transcript: Eli Lilly Q2 2026 Earnings Conference Call
Eli Lilly (NYSE:LLY) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and financial data.
Scholar Rock Holding Reports Q2 2026 Results: Full Earnings Call Transcript
Scholar Rock Holding Reports Q2 2026 Results: Full Earnings Call Transcript
Scholar Rock Holding (NASDAQ:SRRK) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time
Johnson & Johnson Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Johnson & Johnson Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Johnson & Johnson reports Q3 earnings Oct. 13; EPS seen at $2.48, revenue $25.31B. Analysts are mostly bullish after positive Tremfya and Carvykti data.
Alphabet To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Monday
Alphabet To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Monday
Analysts raised targets for Vertex and Okta, while cutting targets for McDonald’s, AutoZone, Vaxcyte and Camping World.
Transcript: Groupe Dynamite Q2 2026 Earnings Conference Call
Transcript: Groupe Dynamite Q2 2026 Earnings Conference Call
On Thursday, Groupe Dynamite (TSX:GRGD) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time
Lululemon Athletica Q2 2026 Earnings Call: Complete Transcript
Lululemon Athletica Q2 2026 Earnings Call: Complete Transcript
Lululemon Athletica (NASDAQ:LULU) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide real-time access
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved